Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1999-3-5
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0033-2240
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
55 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
72
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9857704-Drug Interactions,
pubmed-meshheading:9857704-Erythropoietin,
pubmed-meshheading:9857704-Ferritins,
pubmed-meshheading:9857704-Humans,
pubmed-meshheading:9857704-Injections, Intravenous,
pubmed-meshheading:9857704-Iron,
pubmed-meshheading:9857704-Kidney Diseases,
pubmed-meshheading:9857704-Recombinant Proteins,
pubmed-meshheading:9857704-Renal Dialysis
|
pubmed:year |
1998
|
pubmed:articleTitle |
Iron therapy: overview and recommendations.
|
pubmed:affiliation |
Renal Unit, Kings College Hospital, London, UK.
|
pubmed:publicationType |
Lectures
|